바이오테크 보도자료
-
- Everbridge Features 43rd President of the United States George W. Bush Speaking on Leadership and Critical Event Management, as well as CNN’s Dr. Sanjay Gupta as Day 1 Keynote for COVID-19: Road to Recovery Symposium
- Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced highlights from day one of its two-day Autumn 2020 “COVID-19 R2R: The Road to Recovery” virtual leadership symposium, addressing global best pra...
- 2020년 10월 16일
-
- Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
- Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are for use with any brand of UHPLC system and can meas...
- 2020년 10월 15일
-
- actnano, the Global Leader in Protective Nanocoatings for Automotive & Consumer Electronics, Raises an Oversubscribed $12M Series A Round
- Protective nanocoating company actnano today announced that it has raised $12M in a Series A funding round. Emerald Technology Ventures led the round and was joined by Material Impact, as well as Henkel Tech Ventures, GC Ventures America (PTT Glob...
- 2020년 10월 14일
-
- Takeda Accelerates Digital Transformation with Accenture and AWS
- Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”), Accenture (NYSE: ACN) and Amazon Web Services, Inc. (AWS) have entered into a five-year strategic agreement to accelerate Takeda’s digital transformation. Not only will patien...
- 2020년 10월 14일
-
- Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced interim results from the VISIBLE open-label extension (OLE) study on the long-term safety and efficacy of maintenance treatment with the subcutaneous (SC) formula...
- 2020년 10월 12일
-
- Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
- Galderma today announced the presentation of data from clinical trials of its aesthetic solutions and pipeline in five abstracts at the virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting. The company also announced that i...
- 2020년 10월 12일
-
- Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality
- Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality syste...
- 2020년 10월 12일
-
- Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced a collaboration and licensing agreement to develop ARO-AAT, a Phase 2 investigational RNA interference (RNAi) th...
- 2020년 10월 12일
-
- Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC
- Arima Genomics, Inc., a biotechnology company accelerating the adoption of the genome structure information, announced today that its new high-coverage HiC technology has been evaluated and implemented at the Wellcome Sanger Institute for projects...
- 2020년 10월 07일
-
- ABB Enhances Portfolio of High-Speed Industrial Robots With Codian Acquisition
- ABB has acquired Codian Robotics B.V., a leading provider of delta robots, which are used primarily for high-precision pick and place applications. Codian Robotics’ offering includes a hygienic design line, ideal for hygiene-sensitive industries i...
- 2020년 10월 06일
-
- Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards
- Synaffix B.V., a biotechnology company enabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces that it has won the “Best ADC Platform Technology” category at the 2020 World ADC Awards ceremony. Synaffix’ ADC platfo...
- 2020년 10월 05일
전시회
